WallStreetZenWallStreetZen

NASDAQ: AKTX
Akari Therapeutics PLC Stock Ownership - Who owns Akari Therapeutics?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Akari Therapeutics PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Abizer GaslightwalaCEO2025-06-1020,000$1.27
$25.40kBuy
Raymond PrudochleboszDirector2025-03-06446,428$1.12
$500.00kBuy
Abizer GaslightwalaDirector2025-03-06133,928$1.12
$150.00kBuy
Hoyoung HuhDirector2025-03-06892,857$1.12
$1,000.00kBuy
James R. NealDirector2025-03-064,464$1.12
$5.00kBuy
Samir Rashmikant PatelDirector2025-03-06406,250$1.12
$455.00kBuy
Sandip I. PatelDirector2025-03-0644,642$1.12
$50.00kBuy
Robert B. BazemoreDirector2025-03-0644,642$1.12
$50.00kBuy
Abizer GaslightwalaDirector2025-01-1011,439$1.22
$13.96kBuy
Torsten HombeckCFO2025-01-10200$1.22
$244.00Buy

1 of 3

AKTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AKTX insiders and whales buy or sell their stock.

AKTX Shareholders

What type of owners hold Akari Therapeutics PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Rachelle Suzanne Jacques1.58%1,018,027,792$1.21BInsider
Rpc Pharma Ltd1.12%722,345,600$859.59MInsider
Ray Prudo1.12%722,345,600$859.59MInsider
James Hill1.12%722,345,600$859.59MInsider
Stuart Ungar1.12%722,345,600$859.59MInsider
Hoyoung Huh0.35%223,719,311$266.23MInsider
Wendy F. Dicicco0.25%158,473,915$188.58MInsider
Sandip I. Patel0.19%121,026,008$144.02MInsider
Donald A. Williams0.03%20,000,000$23.80MInsider
Michael Grissinger0.03%20,000,000$23.80MInsider

1 of 3

AKTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AKTX0.00%6.93%Net BuyingNet Buying
IMUX42.22%16.55%Net BuyingNet Buying
PYXS48.83%37.69%Net Buying
ZURA51.74%48.26%Net Selling
EPIX71.37%11.07%Net Selling
View Top Biotech Stocks

Akari Therapeutics Stock Ownership FAQ

Who owns Akari Therapeutics?

Akari Therapeutics (NASDAQ: AKTX) is owned by 0.00% institutional shareholders, 6.93% Akari Therapeutics insiders, and 93.07% retail investors. Rachelle Suzanne Jacques is the largest individual Akari Therapeutics shareholder, owning 1.02B shares representing 1.58% of the company. Rachelle Suzanne Jacques's Akari Therapeutics shares are currently valued at $1.21B.

If you're new to stock investing, here's how to buy Akari Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.